Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDK7 anticorps (AA 212-341)

CDK7 Reactivité: Humain IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7148902
  • Antigène Voir toutes CDK7 Anticorps
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Épitope
    • 32
    • 13
    • 7
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 212-341
    Reactivité
    • 99
    • 29
    • 13
    • 6
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 79
    • 21
    • 1
    Lapin
    Clonalité
    • 73
    • 28
    Polyclonal
    Conjugué
    • 54
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDK7 est non-conjugé
    Application
    • 76
    • 33
    • 33
    • 18
    • 15
    • 14
    • 14
    • 10
    • 9
    • 8
    • 8
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Cyclin-dependent kinase 7 protein (212-341AA)
    Isotype
    IgG
    Top Product
    Discover our top product CDK7 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Autre désignation
    CDK7 (CDK7 Produits)
    Synonymes
    anticorps CAK1, anticorps CDKN7, anticorps HCAK, anticorps MO15, anticorps STK1, anticorps p39MO15, anticorps AI323415, anticorps AI528512, anticorps C230069N13, anticorps Cdkn7, anticorps Crk4, anticorps CD 7, anticorps CDK7, anticorps CG3319, anticorps DmCDK7, anticorps DmCdk7, anticorps DmMO15, anticorps DmMo15, anticorps Dmcdk7, anticorps Dmel\\CG3319, anticorps Mo15, anticorps cdk-7, anticorps cdk7, anticorps dCdk7, anticorps p40[MO15], anticorps p40MO15, anticorps stk1, anticorps zgc:85821, anticorps cak1, anticorps cdkn7, anticorps p39mo15, anticorps cyclin dependent kinase 7, anticorps cyclin-dependent kinase 7, anticorps Cyclin-dependent kinase 7, anticorps cyclin-dependent kinase 7 L homeolog, anticorps CDK7, anticorps Cdk7, anticorps cdk7.L, anticorps cdk7
    Sujet

    Background: Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53, this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

    Aliases: 39 kDa protein kinase antibody, CAK antibody, CAK1 antibody, Cdk activating kinase antibody, CDK-activating kinase 1 antibody, CDK-activating kinase antibody, cdk7 antibody, CDK7_HUMAN antibody, CDKN7 antibody, Cell division protein kinase 7 antibody, Cyclin dependent kinase 7 antibody, cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) antibody, Cyclin-dependent kinase 7 antibody, HCAK antibody, Homolog of Xenopus MO15 Cdk activating kinase antibody, Kinase subunit of CAK antibody, MO15 antibody, MO15, Xenopus, homolog of antibody, P39 Mo15 antibody, p39MO15 antibody, Serine threonine kinase Stk1 antibody, Serine/threonine protein kinase 1 antibody, Serine/threonine protein kinase MO15 antibody, STK1 antibody, TFIIH basal transcription factor complex kinase subunit antibody

    UniProt
    P50613
    Pathways
    Cycle Cellulaire, Réparation de l'ADN, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Vous êtes ici: